NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Paul A Vanderlaan
Harvard University - Cambridge / United States
Medical and Health Sciences / Pathology
AD Scientific Index ID: 1343902
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Paul A Vanderlaan's MOST POPULAR ARTICLES
1-)
The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory NotesSZ Ali, PA VanderLaan1170*2003
2-)
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulatorsPA VanderLaan, CA Reardon, GS GetzArteriosclerosis, thrombosis, and vascular biology 24 (1), 12-22, 20048282004
3-)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMJ Niederst, LV Sequist, JT Poirier, CH Mermel, EL Lockerman, ...Nature communications 6 (1), 6377, 20155892015
4-)
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancersD Rangachari, N Yamaguchi, PA VanderLaan, E Folch, A Mahadevan, ...Lung cancer 88 (1), 108-111, 20154922015
5-)
Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?PA VanderLaan, E Marqusee, JF KraneAmerican Journal of Clinical Pathology 135 (5), 770-775, 20112572011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept